Clinical Trial Update: Intravitreal Aflibercept for Therapy of Patients With Pseudoxanthoma Elasticum (PXE) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating intravitreal aflibercept for therapy in patients with Pseudoxanthoma Elasticum has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pseudoxanthoma Elasticum

Drugs mentioned

• intravitreal aflibercept (aflibercept)

Snippet

Sponsor: University Hospital, Bonn | Conditions: Pseudoxanthoma Elasticum | Phase 2 | Status: COMPLETED